spacer
home > ebr > spring 2018 > data swap
PUBLICATIONS
European Biopharmaceutical Review

Data Swap

Biobanks play a significant role in the drug discovery process by providing researchers access to unique sample sets that can be linked to identifying characteristics, which, in turn, can accurately diagnose disease and predict drug response.

Today’s research biobank typically provides physical sample storage and maintains associated data within their databases. Information about acquisition, quality, state, location, processing outcomes, quantity, and usage are all generally available at a minimum, but are primarily focused on the sample characteristics. However, researchers want to link individualities to attributes of the donor, including phenotypical, demographical, genetic, or lifestyle attributes.

A challenge can present itself between the biobank resources and requirements of the research community. The types and amount of data linked to the physical sample that is needed to identify pertinent information can grow more important and complex. Therefore, meeting the expanding specificity of research programmes requires each sample within a biorepository to be connected to as comprehensive a data array as possible to deliver maximum value.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Thurston is Director of Informatics at Brooks Life Sciences, having joined the company in 2015. He has worked in the field of laboratory informatics for over 20 years and has experience in the development, sales, support and marketing of a variety of laboratory software. A graduate of Salford University, UK, with a BSc in chemistry, Colin began his career researching solid-state secondary lithium batteries.
spacer
Colin Thurston
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement